Truveta Valuation, Funding & Investors

Truveta is valued at $1B as of January 2025.

Last Truveta valuation

$1B

Series C · Jan 2025

Last Truveta funding round

$320M

Series C · Jan 2025

Cumulative funding Truveta raised

$515M

across 3 funding rounds

Key investors in Truveta

  • Providence Health & Services
  • CommonSpirit Health
  • Northwell Health
  • Trinity Health
  • Henry Ford Health
  • Illumina

Truveta Overview

About Truveta

Truveta is a health data company headquartered in Bellevue, Washington, founded in 2020 and owned and governed by a collective of US health systems. It aggregates de-identified electronic health record data from more than 30 member health systems, covering over 120 million patients, and provides that data and analytics to pharmaceutical, medical device, public health and academic customers. Products include the Truveta Data platform launched in 2021, the Truveta Language Model for structuring clinical data introduced in 2023, and the Truveta Genome Project launched in 2025. The company was created by Providence, Advocate Health, Tenet Healthcare and Trinity Health and introduced publicly in February 2021 with 14 founding health system members. Terry Myerson is chief executive. Truveta closed a $95 million Series A funded by its members in 2021 and raised $320 million at a valuation above $1 billion in 2025 from 17 health systems, Regeneron and Illumina. Pfizer was its first life sciences customer and Microsoft supplies its cloud and AI infrastructure.


Founded

2020

HQ

United StatesBellevue, WA

Status

Privately held

Customer focus

B2B

Revenue model

Licensing, Subscription

Valuation

$1B (Jan 2025)

Truveta Valuation

Truveta is currently valued at $1B, based on its Series C in January 2025. Read the announcement ↗

The $320M round included Trinity Health, Henry Ford Health, Providence Health & Services, Regeneron, Advocate Health and 3 other investors.

Truveta's valuation has moved from $1B at its undisclosed-stage round in November 2021 to $1B in January 2025, across 2 priced rounds.

Truveta valuation by funding round

Truveta valuation by funding round
DateStageValuation
Jan 2025Series C$1B
Nov 2021Undisclosed stage$1B

Truveta Funding History

Truveta has raised a total of $515M across 3 funding rounds.

Truveta's first fundraising round was a $95M Series A in July 2021. The most recent completed round was a $320M Series C in January 2025.

Truveta funding rounds

Truveta funding rounds
DateStageInvestorsRaisedValuationDeal Summary
Jan 2025Series CTrinity Health; Henry Ford Health; Providence Health & Services; Regeneron; Advocate Health; Illumina; CommonSpirit Health; Northwell Health$320M$1BTruveta is a Bellevue, Washington-based health data company founded in 2020 that aggregates de-identified electronic health records from over 30 partner health systems, representing more than 120 million patients, to enable clinical insights linking treatments to outcomes for medical research in areas like cardiovascular, neurology, and oncology. The platform supports life sciences, public health, healthcare, and academic organizations with daily-updated data while prioritizing patient privacy and HIPAA compliance. Truveta has grown to over 400 employees and previously raised $95 million in 2021 and additional funding from investors like Microsoft, bringing total funding to nearly $500 million prior to this round. On January 13, 2025, Truveta announced a $320 million growth round from 17 health systems—including Advocate Health, CommonSpirit Health, Henry Ford Health System, Northwell Health, Providence, and Trinity Health—plus strategic investments from Regeneron Pharmaceuticals ($119.5 million) and Illumina ($20 million), achieving unicorn status with a post-money valuation of $1 billion or exceeding $1 billion. The funding supports the Truveta Genome Project, described as the largest and most diverse database of genotypic and phenotypic data, over ten times the scale of NIH’s All of Us or UK Biobank, partnering with Regeneron Genetics Center to sequence exomes of ten million volunteers and using Microsoft Azure as the exclusive cloud provider. This round positions Truveta to advance personalized medicine through early detection and prevention, addressing healthcare costs beyond chronic disease management, with its AI model for extracting data from medical texts enhancing research capabilities. The company ranks highly among Pacific Northwest startups and continues expanding its dataset for demographic-specific insights like ischemic stroke patients.
Nov 2021Undisclosed stage-$100M$1B-
Jul 2021Series AMedStar Health; Trinity Health; AdventHealth; Henry Ford Health; Tenet Healthcare; Hawaii Pacific Health; Providence Health & Services; Bon Secours Mercy Health; Memorial Hermann Health System; Baptist Health; Novant Health; CommonSpirit Health; Baylor Scott & White Health; Texas Health Resources; Sentara Healthcare; Northwell Health; Advocate Aurora Health$95M-Truveta is a provider-led health data platform founded in 2020 and headquartered in Bellevue, Washington, aggregating de-identified patient records from member health systems to accelerate medical research, drug development, and improve patient care. The company launched from stealth in early 2021 with initial backing from 14 health systems including Providence, Advocate Aurora Health, Trinity Health, Tenet Healthcare, Northwell Health, AdventHealth, Baptist Health of Northeast Florida, Bon Secours Mercy Health, CommonSpirit Health, Hawaii Pacific Health, Henry Ford Health System, Memorial Hermann Health System, Novant Health, and Sentara Healthcare. On July 13, 2021, Truveta announced a $95 million Series A funding round fully funded by its health system members in roughly equal amounts, reflecting shared ownership and governance, with leaders from these systems holding voting seats on the board. The round coincided with the addition of three new members—Baylor Scott & White Health, MedStar Health, and Texas Health Resources—bringing the total to 17 members representing over 15% of all U.S. patient care across tens of millions of patients and thousands of facilities in 40 states. Proceeds from the Series A were allocated to hiring machine learning engineers, clinical informaticists, data engineers, technologists, and health data experts, as well as funding infrastructure and cloud-computing costs to build the Truveta platform for ethical research linking treatments to outcomes. CEO Terry Myerson, a former Microsoft executive, emphasized the platform's potential to answer critical questions on treatment efficacy, at-risk populations, and optimized care, accelerated by COVID-19 data needs. Truveta operates as a tax-paying for-profit entity, with member earnings reinvested into communities. The funding validated Truveta's model amid growing demand for consolidated healthcare data, positioning it uniquely through multi-system coordination and governance. At the time, the company had around 100 employees and aimed to scale operations.

Who has invested in Truveta?

20 investors have backed Truveta across its funding rounds, including Providence Health & Services, CommonSpirit Health, Northwell Health, Trinity Health, Henry Ford Health and Illumina.


Truveta Investors

Investors in Truveta by funding rounds participated
InvestorHQRoundsRoleFirst check
Trinity HealthUnited StatesLivonia2ParticipantJul 2021
Henry Ford HealthUnited StatesDetroit, MI2ParticipantJul 2021
Providence Health & ServicesUnited StatesRenton, WA2ParticipantJul 2021
CommonSpirit HealthUnited StatesChicago, IL2ParticipantJul 2021
Northwell HealthUnited StatesNew Hyde Park, NY2ParticipantJul 2021
MedStar HealthUnited StatesColumbia, MD1ParticipantJul 2021
AdventHealthUnited StatesAltamonte Springs, FL1ParticipantJul 2021
Tenet HealthcareUnited StatesDallas, TX1ParticipantJul 2021
Hawaii Pacific HealthUnited StatesHonolulu, HI1ParticipantJul 2021
Bon Secours Mercy HealthUnited StatesCincinnati, OH1ParticipantJul 2021
RegeneronUnited StatesTarrytown1ParticipantJan 2025
Advocate HealthUnited StatesCharlotte, NC1ParticipantJan 2025
Memorial Hermann Health SystemUnited StatesHouston, TX1ParticipantJul 2021

This data is available for Pro users. Sign up to see all 20 Truveta investors.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

Truveta Competitors

Truveta competitors include listed companies like Indegene and Veradigm, and private ones like HealthVerity, Unite Us, Arine and Medbanks.

Public and private companies comparable to Truveta
CompanyHQStatusRevenueEBITDAValuationRevenue Multiple
HealthVerityUnited StatesPhiladelphia, PAPrivate--$721M-
IndegeneIndiaIndiaPublicly listed$373M$69M$1.6B3.3x
Unite UsUnited StatesNew York City, NYPrivate--$1.6B-
VeradigmUnited StatesUnited StatesPublicly listed$588M$54M$523M0.9x
ArineUnited StatesSan Francisco, CAPrivate--$520M-
MedbanksChinaBeijingPrivate--$430M-

Truveta Public Comps

Truveta is still privately-owned, but its public comps include iFLYHealth, MedicalSystem Technology, Omada Health, PHC Holdings, HealthStream, Lunit, B-Soft Co., Hangzhou Pinming Software, Vitec Software and Phreesia.

Last FYEV/RevenueEV/EBITDA
RevenueEBITDALast FYLTM2027ELast FYLTM2027E
iFLYHealth$137M($7M)7.5x5.9x(147.8x)517.8x
MedicalSystem Technology$45M$12M22.4x17.8x83.7x69.6x
Omada Health$260M($10M)2.7x2.1x(68.8x)24.9x
PHC Holdings$2.3B$315M1.0x1.0x7.1x6.0x
HealthStream$304M$63M2.6x2.4x12.3x10.2x
Lunit$61M($9M)13.0x12.4x(91.1x)(15.4x)
B-Soft Co.$158M($37M)5.0x5.1x(20.9x)(21.0x)
Hangzhou Pinming Software$66M$8M11.4x10.9x91.4x-

This data is available for Pro users. Sign up to see all Truveta competitors and their valuation data.

Start Free Trial

Common questions about Truveta

When was Truveta founded?Truveta was founded in 2020.
Where is Truveta headquartered?Truveta is headquartered in Bellevue, WA, United States.
Is Truveta publicly listed?No, Truveta is a private, VC-backed company.
What is Truveta's valuation?Truveta was last valued at $1B in its Series C in January 2025.
How much funding has Truveta raised?Truveta has raised $515M across 3 funding rounds.
What was Truveta's last funding round?Truveta's last funding round was a $320M Series C in January 2025.
Who are Truveta's investors?Truveta's investors include Trinity Health, Henry Ford Health, Providence Health & Services, CommonSpirit Health, Northwell Health, MedStar Health, AdventHealth, Tenet Healthcare, Hawaii Pacific Health, Bon Secours Mercy Health and 10 others.
Which companies are comparable to Truveta?Companies comparable to Truveta include HealthVerity, Indegene, Unite Us, Veradigm, Arine and Medbanks.

See companies similar to Truveta

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial